期刊文献+

EP4A对人CD34^+细胞干性因子表达的影响

Effects of Prostaglandin E2 Receptor 4 Agonist on the Expression of Stem Factors in Human CD34^+ Cells
下载PDF
导出
摘要 目的:探讨前列腺素E2特异性受体激动剂4(EP4A)增强人CD34^+细胞干性因子表达的机制。方法:收集中山大学附属第一医院血液科20例健康供者经G-CSF动员后的外周血造血干细胞采集物,采用免疫磁珠法分选出人CD34^+细胞。以DMSO作对照,分别用EP4A、EP4A+EP4A拮抗剂(EP4AA)作用人CD34^+细胞72 h后,应用热图和Pathway富集分析检测与CD34^+细胞干性相关的差异基因和通路;再用qRT-PCR和Western blot检测不同组别细胞中通路蛋白和差异基因的mRNA及蛋白(β-catenin、Nanog、Oct4、Sox2、Stat3、AKT、P38)表达水平。结果:与对照组相比,EP4A组人CD34^+细胞中β-catenin、Nanog、Oct4及Sox2 mRNA及其蛋白的表达均增高,而STAT3、AKT、P38 mRNA及其蛋白的表达无变化;EP4A与EP4AA(XAV939)共同作用人CD34^+细胞时,人CD34^+细胞β-catenin表达水平明显降低,并且Nanog、Oct4及Sox2基因及蛋白表达相应减少。结论:EP4A可增加人CD34^+细胞干性因子(β-catenin、Nanog、Oct4和Sox2)表达,而不能增加STAT3、AKT、P38表达。 Objective:To investigate the effect of prostaglandin E2 recoptor 4 antagonist(EP4A)on the self-renewal ability of human CD34^+cells and its mechamism.Methods:The peripheral blood hematopoietic stem cell of 20 healthy donors received the G-CSF-mobilization were collected,then the human CD34^+cells were sorted out by MACS microbead kit.The human CD34^+cells were treated with DMSO(control group),EP4A(EP4A group)and EP4A+EP4A antagonist(EP4A+EP4A group)for 72 hours.The differential genes and pathways related with CD34^+cell stemness were detected by Thermogram and Pathway enrichment analysis.and then the expression levels of protein and gene(β-catenin,Nanog,Oct4,Sox2,Stat3,AKT,P38)were detected by qRT-PCR and Western blot respectively.Results:EP4A could elevate the mRNA and protein expression ofβ-catenin,Nanog,Oct4,Sox2,in comparison with control group,however,mRNA and protein expression of STAT3,AKT,P38 were not changed.When human CD34^+cell were cultured with EP4A+XAV939 it was found that the mRNA and protein expression ofβ-catenin was downregulated,moreover the mRNA and protein expression of Nanog,Oct4,Sox2 were reduced.Conclusion:EP4A can upregulate stemness factors-β-catenin,Nanog,Oct4 and Sox2 in human CD34^+cell in vitro,but not STAT3,AKT and P38.
作者 黎春明 刘芳洁 汪亚群 唐晶 陈惠珍 李娟 许多荣 LI Chun-Ming;LIU Fang-Jie;WANG Yan-Qun;TANG Jing;CHEN Hui-Zhen;LI Juan;XU Duo-Rong(Department of Hematology,The First Affiliated Hospital of SUN Yat-Sen University,Guangzhou 510080,Guangdong Province,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2020年第1期275-282,共8页 Journal of Experimental Hematology
关键词 造血干细胞 EP4受体激动剂 干性 hematopoietic stem cell EP4 agonist stemness
  • 相关文献

参考文献2

二级参考文献18

  • 1Le Blanc K, Ringd6n O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 2005 ; 11 ( 5 ) : 321 - 334.
  • 2Angelopoulou M, Novelli E, Grove JE, et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol, 2003; 31 (5) : 413 - 420.
  • 3Di Ianni M, Del Papa B, De Ioanni M, et al. Mesenchymal cells : a vehicle for gene therapy. Blood Cells Mol Dis, 2004 ; 33 ( 3 ) : 267 - 270.
  • 4Li J, Law HK, Lan YL, et al. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol, 2004; 127(3) : 326 -334.
  • 5Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells. Gene, 2009 ; 433 ( 1 - 2 ) : 1 - 7.
  • 6Neth P, Ciccarella M, Egea V, et al. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells, 2006; 24(8) : 1892 -1903.
  • 7Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy, 2009 ; 11 (5) : 503 - 515.
  • 8Baron F, Lechanteur C, Willems E, et al. Cotransplantation of mesenchymal stem ceils might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biol Blood Marrow Transplant, 2010; 16 (6) : 838 -847.
  • 9Braess J, Spiekermann K, Staib P, et al. Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG. Blood, 2009; 113(17) : 3903 -3910.
  • 10Huelsken J, Birchmeier W. New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev, 2001 ; 11 (5) : 547 - 553.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部